(Q44594417)

4 December 2017

title

Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone (English)

1 reference

hypogonadotropic hypogonadism

4 December 2017

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(03)00186-0

13 March 2024

author name string

Barnett Zumoff

series ordinal

1

1 reference

4 December 2017

Lorraine K. Miller

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506617

13 March 2024

Gladys W. Strain

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506617

13 March 2024

language of work or name

1 reference

1 September 2003

1 reference

full work available at URL

4 December 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0026049503001860?httpAccept=text/plain

1 reference

DOI

https://api.crossref.org/works/10.1016/S0026-0495(03)00186-0

https://api.elsevier.com/content/article/PII:S0026049503001860?httpAccept=text/xml

13 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0026-0495(03)00186-0

13 March 2024

1 reference

4 December 2017

volume

52

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1126-1128

1 reference

Obese young men have elevated plasma estrogen levels but obese premenopausal women do not

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Mild Hypogonadotropic hypogonadism in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

The effect of weight loss on reproductive hormones in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Endogenous opioids and hypogonadism in human obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900186-0

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference